Pharmafile Logo
Pharmafocus logo
Advanced Search

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026
Research and Development Cardiology, Rhythm AI, atrial fibrillation

Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …

News

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026
Manufacturing and Production iOrganBio

iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …

Appointment

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026
Business Services, Consultancy Ensera Design

Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …

Appointment

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026
Research and Development Infinitopes, Oncology

Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …

News

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026
Angelini Pharma

Angelini Pharma, the pharmaceutical branch of Angelini Industries, has announced the appointment of Roberto Scrivo as Chief of External Affairs, …

Appointment

Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production

February 10, 2026
Manufacturing and Production Hongene Biotech, mRNA vaccine

Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …

News

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026
Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …

News

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026
AstronauTx, chair of the board

AstronauTx has announced the appointment of Adam Rosenberg as Chair of its Board of Directors. Rosenberg’s leadership experience includes holding …

Appointment

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026
Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …

News

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026
Angelini Pharma, CEO

Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …

Appointment

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026
Research and Development Oncology, QV Bioelectronics, glioblastoma

QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …

News

Alvotech appoints Lisa Graver as CEO

February 3, 2026
Alvotech, CEO

Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …

Appointment

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026
Research and Development HonorHealth Research Institute, Neurology, ischemic stroke

HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …

News

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026
Accord healthcare, Associate Vice President, Country Head

Accord Healthcare has announced the appointment of Paul Burden as Associate Vice President and Country Head of Accord UK. Burden …

Appointment

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026
Medical Communications United Nations, WHO, healthcare access, mental health, noncommunicable diseases, primary care

The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental health challenges and noncommunicable diseases …

Feature

Rare diseases – spinal muscular atrophy

January 30, 2026
Medical Communications gene therapy, medical communications, muscle and motor function, muscle weakness, rare diseases, sma

Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can lead to difficulties in activities …

Feature

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026
Medical Communications, Research and Development Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility

By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …

Feature

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026
Medical Communications MHRA, NHS, NICE, Wellcome, digital technologies, medical communications, mental health

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together with other forms of care, …

Feature

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026
Research and Development Barts Health NHS Trust, H.I.G. Realty, health innovation

Barts Health NHS Trust and H.I.G. Realty have announced a collaboration to launch an applied healthcare innovation building in the …

News

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026
Head of Business Development US, Rentschler Biopharma

Rentschler Biopharma has announced the appointment of Detra Glinatsis as Head of Business Development US. Glinatsis brings more than two …

Appointment

Five Facts about spinal muscular atrophy

January 28, 2026
Medical Communications Five Facts, Neurology, early diagnosis, five types, gene therapy, muscle weakness, spinal muscular atrophy

1 Spinal muscular atrophy (SMA) is a genetic disease involving the loss of motor neurons in the spinal cord.1 Its …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026